triazinate has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for triazinate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Pancreatic Neoplasms; Triazines | 1987 |